手動蘇生器：市場洞察・競合環境・市場予測 (～2030年)

手動蘇生器の市場規模は、2024年から2030年までの予測期間中にCAGR 6.13%で成長すると予測されています。

手動蘇生器の市場は、心停止や慢性閉塞性肺疾患 (COPD) などの心肺および呼吸器疾患の発生率の増加など、いくつかの主要要因によって牽引されています。また、病院外での心停止、外傷、事故の発生率の高さも、緊急用手動蘇生器のニーズを高めています。さらに、老年人口の増加や、世界中のメーカーによる手動蘇生器の新製品や改良品の継続的な展開も予測期間中の市場成長を後押ししています。

Resuscitation Council UKが提供した最新データによると、2021年の院外心停止 (OHCA) の年間発生率は人口10万人当たり約55人でした。心停止の大部分 (72％) は家庭で発生しており、さらに15％は職場で発生しています。心停止の大部分 (98％) は成人で発生し、その3分の1 (33％) は15～64歳です。院内心停止 (IHCA) の年間発生率は、入院患者1,000人あたり1～1.5人です。IHCAを起こした人の平均年齢は70歳で、4分の1 (26.7％) は16～64歳です。このように、院外および院内での心停止の発生率が上昇していることから、手動蘇生器の重要な必要性が浮き彫りになっています。医療提供者、救急隊員、公衆衛生機関は、生存率と患者の転帰を改善することにますます重点を置くようになっており、高品質の手動蘇生器の需要を牽引しています。さらに、意識の高まりと即時対応能力に対する重要なニーズは、直接的に手動蘇生器に対する需要の急増につながり、市場の成長と蘇生技術の革新に拍車をかけています。

また、WHOの最新データ (2023年) によると、COPDの患者数は世界で3億9,200万人と推定されています。さらに、Australian Institute of Health and Welfareが提供したデータ (2023年) によると、COPDは、2023年の呼吸器疾患負担の50％、全疾患負担では3.6％を占めています。COPDは世界の罹患率と死亡率の主要原因であり、しばしば重度の呼吸困難や急性増悪を引き起こし、早急な呼吸器サポートが必要となります。COPD患者の増加に伴い、緊急時に効率的で信頼性の高い酸素供給が可能な手動蘇生器の需要も増加し、市場全体を押し上げています。

当レポートでは、世界の手動蘇生器の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 手動蘇生器市場：イントロダクション

第2章 手動蘇生器市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 手動蘇生器市場：主要要因分析

• 市場促進要因
  • COPDの罹患率の増加
  • 心肺停止の発生率の増加
  • 蘇生についての意識の向上
• 市場抑制要因と課題
  • 手動蘇生器に関連する合併症
  • 緊急時に呼吸補助を提供する代替手段の存在
• 手動蘇生器の市場機会
  • 電気インピーダンストモグラフィー (EIT) 技術に関する継続的なR&D活動

第6章 手動蘇生器市場：ポーターのファイブフォース分析

第7章 手動蘇生器市場：市場評価

• タイプ別
  • 自己膨張式
  • 流量膨張式
• 用途別
  • 使い捨て
  • 再利用可能
• 患者別
  • 大人
  • 新生児
  • 小児
• 用途別
  • 心肺閉塞性疾患 (COPD)
  • 心肺停止
  • その他
• エンドユーザー別
  • 病院・クリニック
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 手動蘇生器市場：企業および製品プロファイル

• Vyaire Medical Inc.
• Ambu A/S
• Teleflex Inc.
• Zeal Medical Private Limited
• Medline Industries Inc.
• Allied Healthcare
• GE Healthcare
• Drager Medical AG and Co.
• Laerdal Medical
• Hopkins Medical Products
• Mercury Medical
• Cardinal Health
• Bayer AG
• McKesson Corporation
• Romsons

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Manual Resuscitators Market in Global (2021-2030)
• Table 3: Manual Resuscitators Market in Global by Type (2021-2030)
• Table 4: Manual Resuscitators Market in Global by Usage (2021-2030)
• Table 5: Manual Resuscitators Market in Global by Patient (2021-2030)
• Table 6: Manual Resuscitators Market in Global by Application (2021-2030)
• Table 7: Manual Resuscitators Market in Global by End-user (2021-2030)
• Table 8: Manual Resuscitators Market in Global by Geography (2021-2030)
• Table 9: Manual Resuscitators Market in North America (2021-2030)
• Table 10: Manual Resuscitators Market in the United States (2021-2030)
• Table 11: Manual Resuscitators Market in Canada (2021-2030)
• Table 12: Manual Resuscitators Market in Mexico (2021-2030)
• Table 13: Manual Resuscitators Market in Europe (2021-2030)
• Table 14: Manual Resuscitators Market in France (2021-2030)
• Table 15: Manual Resuscitators Market in Germany (2021-2030)
• Table 16: Manual Resuscitators Market in United Kingdom (2021-2030)
• Table 17: Manual Resuscitators Market in Italy (2021-2030)
• Table 18: Manual Resuscitators Market in Spain (2021-2030)
• Table 19: Manual Resuscitators Market in the Rest of Europe (2021-2030)
• Table 20: Manual Resuscitators Market in Asia-Pacific (2021-2030)
• Table 21: Manual Resuscitators Market in China (2021-2030)
• Table 22: Manual Resuscitators Market in Japan (2021-2030)
• Table 23: Manual Resuscitators Market in India (2021-2030)
• Table 24: Manual Resuscitators Market in Australia (2021-2030)
• Table 25: Manual Resuscitators Market in South Korea (2021-2030)
• Table 26: Manual Resuscitators Market in Rest of Asia-Pacific (2021-2030)
• Table 27: Manual Resuscitators Market in the Rest of the World (2021-2030)
• Table 28: Manual Resuscitators Market in the Middle East (2021-2030)
• Table 29: Manual Resuscitators Market in Africa (2021-2030)
• Table 30: Manual Resuscitators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Manual Resuscitators Market in Global (2021-2030)
• Figure 3: Manual Resuscitators Market in Global by Type (2021-2030)
• Figure 4: Manual Resuscitators Market in Global by Usage (2021-2030)
• Figure 5: Manual Resuscitators Market in Global by Patient (2021-2030)
• Figure 6: Manual Resuscitators Market in Global by Application (2021-2030)
• Figure 7: Manual Resuscitators Market in Global by End-user (2021-2030)
• Figure 8: Manual Resuscitators Market in Global by Geography (2021-2030)
• Figure 9: Manual Resuscitators Market in North America (2021-2030)
• Figure 10: Manual Resuscitators Market in the United States (2021-2030)
• Figure 11: Manual Resuscitators Market in Canada (2021-2030)
• Figure 12: Manual Resuscitators Market in Mexico (2021-2030)
• Figure 13: Manual Resuscitators Market in Europe (2021-2030)
• Figure 14: Manual Resuscitators Market in France (2021-2030)
• Figure 15: Manual Resuscitators Market in Germany (2021-2030)
• Figure 16: Manual Resuscitators Market in United Kingdom (2021-2030)
• Figure 17: Manual Resuscitators Market in Italy (2021-2030)
• Figure 18: Manual Resuscitators Market in Spain (2021-2030)
• Figure 19: Manual Resuscitators Market in the Rest of Europe (2021-2030)
• Figure 20: Manual Resuscitators Market in Asia-Pacific (2021-2030)
• Figure 21: Manual Resuscitators Market in China (2021-2030)
• Figure 22: Manual Resuscitators Market in Japan (2021-2030)
• Figure 23: Manual Resuscitators Market in India (2021-2030)
• Figure 24: Manual Resuscitators Market in Australia (2021-2030)
• Figure 25: Manual Resuscitators Market in South Korea (2021-2030)
• Figure 26: Manual Resuscitators Market in Rest of Asia-Pacific (2021-2030)
• Figure 27: Manual Resuscitators Market in the Rest of the World (2021-2030)
• Figure 28: Manual Resuscitators Market in the Middle East (2021-2030)
• Figure 29: Manual Resuscitators Market in Africa (2021-2030)
• Figure 30: Manual Resuscitators Market in South America (2021-2030)
• Figure 31: Market Drivers
• Figure 32: Market Barriers
• Figure 33: Market Opportunities
• Figure 34: PORTER'S Five Force Analysis

Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of cardiopulmonary obstructive disorders (COPD), increasing prevalence of cardiac pulmonary arrest, and increasing awareness about resuscitation across the globe.

The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.

Manual Resuscitators Market Dynamics

According to the latest data provided by the Resuscitation Council UK (2021), in 2021, the annual incidence of out-of-hospital cardiac arrest (OHCA) was approximately 55 per 100,000 inhabitants. Most cardiac arrests (72%) occur in the home, with an additional 15% occurring in the workplace. The vast majority of cardiac arrests (98%) occur in adults, with one-third (33%) of these adults aged 15-64 years. The annual incidence of in-hospital cardiac arrest (IHCA) is 1 to 1.5 per 1,000 hospital admissions. The average age of individuals sustaining an IHCA is 70 years, with a quarter (26.7%) aged 16-64 years. Thus, the rising incidence of both out-of-hospital and in-hospital cardiac arrests underscored the critical need for manual resuscitators. Healthcare providers, emergency responders, and public health organizations are increasingly focused on improving survival rates and patient outcomes, driving the demand for high-quality manual resuscitators. Additionally, the heightened awareness and the critical need for immediate response capabilities directly translate into a surge in demand for manual resuscitators, fueling market growth and innovation in resuscitation technologies.

Additionally, as per the latest data provided by the World Health Organization (2023), it was estimated that there were 392 million cases of COPD globally. Furthermore, as per the data provided by the Australian Institute of Health and Welfare (2023), COPD accounted for 3.6% of the total disease burden from 50% of the burden of respiratory conditions in 2023. COPD, a leading cause of morbidity and mortality worldwide, often leads to severe respiratory distress and acute exacerbations that require immediate respiratory support. As the number of COPD patients rises, so does the demand for manual resuscitators which are capable of providing efficient and reliable oxygen during emergencies thereby boosting the overall market.

Additionally, the market is expected to see a boost from the approval of newly developed resuscitators. For instance, in October 2022, Laerdal Medical announced that its NeoNatalie Resuscitator received approval under the new EU Medical Device Regulation (MDR). Thus, the increasing product approvals and new launches boost the market for manual resuscitators by expanding reach, increasing product visibility, optimizing distribution, offering targeted sales and support, and creating market differentiation and competitive advantages.

However, the complications associated with manual resuscitators and the presence of alternative methods that provide respiratory support in emergencies may result in slight obstacles to the growth of the manual resuscitators market.

Manual Resuscitators Market Segment Analysis:

Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the patient segment of the manual resuscitators market, the neonatal category is estimated to have a significant revenue share in the manual resuscitators market in 2023. The applications of neonatal resuscitators provide effective respiratory support tailored to the delicate needs of newborn infants. These resuscitators are designed to accommodate the unique physiology of newborns, including their smaller airways and respiratory requirements. Neonatal resuscitators are user-friendly and are often designed for ease of use in high-stress environments such as delivery rooms and NICUs. Neonatal resuscitators are boosting the overall resuscitator market more significantly due to the critical need for effective neonatal care. The specialized nature of these devices, coupled with increased awareness, regulatory support, and focused investments in neonatal healthcare infrastructure, drives their higher market demand and growth compared to other types of resuscitators.

Additionally, the rising number of preterm births, which often require respiratory support, further boosts the market for neonatal resuscitation devices. For instance, as per the latest data provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm in 2020. Furthermore, as per the data provided by the Pan America Health Organization (2023), of every 10 babies born, 1 is preterm and every 40 seconds, 1 of those babies dies across the world. The underdeveloped lungs of preterm infants are not fully equipped to handle the transition to breathing air outside the womb. As a result, many premature babies experience respiratory distress syndrome, thus the need for resuscitators in preterm infants is further increased thereby boosting the market of infant resuscitators and thus boosting the overall market of resuscitators.

Thus, due to the above-mentioned factors, the neonatal category is estimated to amass significant revenue, which will further in return boost the market for manual resuscitators during the forecast period.

North America Is Expected To Dominate The Overall Manual Resuscitators Market:

North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The burgeoning market for manual resuscitators is underpinned by a complex interplay of factors, each contributing to its rapid expansion. Chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest are significant health challenges that drive the demand for manual resuscitators in North America. COPD, affects millions of people in the region, leading to frequent exacerbations that require immediate respiratory support. Furthermore, the growing awareness and implementation of resuscitation education programs further enhances the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.

According to recent data provided by the Heart and Stroke Statistics (2022), there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S. The incidence of emergency medical services-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Thus, the data serve as a compelling driver for the manual resuscitator market in the region. Healthcare providers, emergency responders, and public health organizations are increasingly recognizing the need for quick and effective intervention in cardiac arrest scenarios. This recognition is likely to spur investments in resuscitators that can enhance the chances of survival for cardiac arrest victims thereby boosting the market for manual resuscitators in the region.

As per the recent data provided by American Lung Association (2024) findings, approximately 1.7 million adults, constituting 4.6% of the adult population of the US, had reported a diagnosis of COPD, encompassing chronic bronchitis or emphysema. Notably, there was a higher prevalence of COPD among women than men, as well as among individuals aged 65 and older compared to younger age brackets. In conclusion, the rising prevalence of COPD in the US is anticipated to fuel the growth of the manual resuscitator market in the US, which will in return fuel the market growth for manual resuscitators in North America.

Thus, the above mentioned factors are expected to escalate the market of manual resuscitators in the region.

Manual Resuscitators Market Key Players:

Some of the key market players operating in the manual resuscitators market include Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.

Recent Developmental Activities In The Manual Resuscitators Market:

• In October 2023, Mercury Medical donates Neo-Tee(R) T-Piece Resuscitators to Neonatologists in Africa.
• In April 2022, South Bruce Grey Health Centre launched a new digital resuscitation education program in partnership with the American Heart Association and Laerdal Medical. Endorsed by the Heart and Stroke Foundation of Canada, the Resuscitation Quality Improvement (RQI) program offered training in Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and Paediatric Advanced Life Support (PALS).

Key Takeaways From The Manual Resuscitators Market Report Study

• Market size analysis for current manual resuscitators size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the manual resuscitators market.
• Various opportunities available for the other competitors in the manual resuscitators market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current manual resuscitators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for manual resuscitators market growth in the coming future?

Target Audience Who Can Be Benefited From This Manual Resuscitators Market Report Study

• Manual resuscitators product providers
• Research organizations and consulting companies
• Manual resuscitators -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in manual resuscitators
• Various end-users who want to know more about the manual resuscitators market and the latest technological developments in the manual resuscitators market.

Frequently Asked Questions For The Manual Resuscitators Market:

1. What are manual resuscitators?

Manual resuscitators, also known as bag-valve-mask (BVM) devices or self-inflating bags, are essential medical devices used to provide positive pressure ventilation to patients who are not breathing adequately or are in respiratory distress. These devices are commonly used in emergency and critical care settings, including hospitals, ambulances, and clinics.

2. What is the market for manual resuscitators?

The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the manual resuscitators market?

The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.

4. Who are the key players operating in the manual resuscitators market?

Some of the key market players operating in the manual resuscitators are Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.

5. Which region has the highest share in the manual resuscitators market?

North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest is a major driver boosting the demand for manual resuscitators in North America. Furthermore, the growing awareness and implementation of resuscitation education programs enhance the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.

Table of Contents

1. Manual Resuscitators Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Manual Resuscitators Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Manual Resuscitators Market Key Factors Analysis

• 5.1. Manual Resuscitators Market Drivers
  • 5.1.1. Growing prevalence of cardiopulmonary obstructive disorders (COPD)
  • 5.1.2. Increasing prevalence of cardiac pulmonary arrest
  • 5.1.3. Increasing awareness about resuscitation across the globe.
• 5.2. Manual Resuscitators Market Restraints and Challenges
  • 5.2.1. Complications associated with manual resuscitators
  • 5.2.2. The presence of alternative methods that provide respiratory support in emergencies
• 5.3. Manual Resuscitators Market Opportunities
  • 5.3.1. Ongoing research & developmental activities on electrical impedance tomography (EIT) technique

6. Manual Resuscitators Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Manual Resuscitators Market Assessment

• 7.1. By Type
  • 7.1.1. Self-Inflating
  • 7.1.2. Flow-Inflating
• 7.2. By Usage
  • 7.2.1. Disposable
  • 7.2.2. Reusable
• 7.3. By Patient
  • 7.3.1. Adults
  • 7.3.2. Neonatal
  • 7.3.3. Pediatric
• 7.4. By Application
  • 7.4.1. Cardiopulmonary Obstructive Disorders (COPD)
  • 7.4.2. Cardiac Pulmonary Arrest
  • 7.4.3. Others
• 7.5. By End-user
  • 7.5.1. Hospitals & Clinics
  • 7.5.2. Ambulatory Surgical Centers
  • 7.5.3. Others
• 7.6. By Geography
  • 7.6.1. North America
    • 7.6.1.1. United States Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.1.2. Canada Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.1.3. Mexico Manual Resuscitators Market Size in USD Million (2021-2030)
  • 7.6.2. Europe
    • 7.6.2.1. France Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2.2. Germany Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2.3. United Kingdom Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2.4. Italy Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2.5. Spain Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2.6. Rest of Europe Manual Resuscitators Market Size in USD Million (2021-2030)
  • 7.6.3. Asia-Pacific
    • 7.6.3.1. China Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3.2. Japan Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3.3. India Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3.4. Australia Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3.5. South Korea Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3.6. Rest of Asia-Pacific Manual Resuscitators Market Size in USD Million (2021-2030)
  • 7.6.4. Rest of the World (RoW)
    • 7.6.4.1. Middle East Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.4.2. Africa Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.4.3. South America Manual Resuscitators Market Size in USD Million (2021-2030)

8. Manual Resuscitators Market Company and Product Profiles

• 8.1. Vyaire Medical Inc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Ambu A/S
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Teleflex Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Zeal Medical Private Limited
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Medline Industries Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Allied Healthcare
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. GE Healthcare
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Drager Medical AG and Co.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Laerdal Medical
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Hopkins Medical Products
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Mercury Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Cardinal Health
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Bayer AG
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. McKesson Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Romsons
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us